In this edition, increased lung cancer screening improving outcomes, overall survival data from FLAURA2 trial and more. Read the full coverage here:

Increased lung cancer screening improving outcomes, but rates 'still too low'

VIDEO: Overall survival data from FLAURA2 trial presented at WCLC

Updated NCCN guidelines on NSCLC put spotlight on biomarker testing 'Never too late': Smoking cessation after cancer diagnosis can extend survival New treatments worsened income-based survival disparities for lung cancer, melanoma References

· American Lung Association 2025 State of Lung Cancer.

· Khor S, et al. JCO Oncol Adv. 2025;doi:10.1200/OA-25-00026.

· National Comprehensive Cancer Network.

· Planchard D, et al. Abstract PL02.06. Presented at IASLC World Conference on Lung Cancer; Sept. 6-9, 2025; Barcelona.

· Tohmasi S, et al. J Natl Compr Canc Netw. 2025;doi:10.6004/jnccn.2025.7059.